Table 2 KEGG pathways enriched in MACS-identified genes differentially acetylated for H4K5 in FC and control in hippocampus
From: Genome-wide analysis of H4K5 acetylation associated with fear memory in mice
Pathway | Treatment | Enrichment ratio | P-value* |
|---|---|---|---|
O-Glycan biosynthesis | FC | 64.22 | 0.0005 |
Calcium signaling pathway | FC | 13.29 | 0.0015 |
mTOR signaling pathway | FC | 32.11 | 0.0018 |
Acute myeloid leukemia | FC | 29.48 | 0.0021 |
Alzheimer's disease | FC | 10.18 | 0.0033 |
Chronic myeloid leukemia | FC | 21.16 | 0.0041 |
Cardiac muscle contraction | FC | 20.43 | 0.0044 |
ErbB signaling pathway | FC | 19.34 | 0.0049 |
Fc gamma R-mediated phagocytosis | FC | 17.13 | 0.0062 |
Metabolic pathways | FC | 3.66 | 0.012 |
Axon guidance | Control | 32.99 | 0.0001 |
Calcium signaling pathway | Control | 22.59 | 0.0003 |
Regulation of actin cytoskeleton | Control | 20.2 | 0.0005 |
Long-term depression | Control | 39.19 | 0.0012 |
Gap junction | Control | 32.52 | 0.0018 |
Small cell lung cancer | Control | 32.52 | 0.0018 |
GnRH signaling pathway | Control | 29.68 | 0.0021 |
Melanogenesis | Control | 28.84 | 0.0022 |
Vascular smooth muscle contraction | Control | 22.99 | 0.0035 |
Focal adhesion | Control | 14.77 | 0.0082 |